Philanthropia

The giving app that gives back

My Philanthropia

Give

  • Charities
    • Charities By City
    • Charities By SDGs
  • Public Portfolios

Philanthropia

Philanthropia

Philanthropia

Give

  • Charities
    • Charities By City
    • Charities By SDGs
  • Public Portfolios
    Amyloidosis Foundation Logo

    MIP Score

    63

    Med Research
    Down Syndrome Research

    Amyloidosis Foundation

    Amyloidosis Foundation Logo

    Amyloidosis Foundation

    Med Research
    Down Syndrome Research
    7151 N Main St, Ste 2, Clarkston, Michigan, 48346View all Clarkston charities
    EIN: 20-0291856
    Total Assets: $1.056 million
    Established in 2003

    Mission

    The Amyloidosis Foundation is dedicated to improving the diagnosis and treatment of amyloidosis, a rare and often misdiagnosed disease caused by the deposition of amyloid proteins in various organs. The foundation focuses on increasing awareness, providing patient resources, funding research, and supporting medical education to advance the understanding and management of amyloidosis.

    Read more on their website →

    Basic Information

    Tax-Exempt

    Address

    7151 N Main St, Ste 2, Clarkston, Michigan, 48346

    View all Clarkston charities

    Founded in

    2003

    EIN

    20-0291856

    Total Assets

    $1.056 million

    Mission

    The Amyloidosis Foundation is dedicated to improving the diagnosis and treatment of amyloidosis, a rare and often misdiagnosed disease caused by the deposition of amyloid proteins in various organs. The foundation focuses on increasing awareness, providing patient resources, funding research, and supporting medical education to advance the understanding and management of amyloidosis.

    Basic Information

    Tax-Exempt

    Address

    7151 N Main St, Ste 2, Clarkston, Michigan, 48346

    View all Clarkston charities

    Founded in

    2003

    EIN

    20-0291856

    Total Assets

    $1.056 million

    UN Sustainable Development Goals Supported

    This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.

    Showing 3 of 3 goals

    Goal 3

    Good Health

    Goal 4

    Quality Education

    Goal 10

    Reduced Inequalities

    Goal 3

    Good Health

    Goal 4

    Quality Education

    Goal 10

    Reduced Inequalities

    At a Glance

    AL Amyloidosis Overview

    AL Amyloidosis Overview

    Information on AL amyloidosis including symptoms, diagnosis, and treatment options.

    Upcoming Events

    Upcoming Events

    Stay informed about our events, including webinars and conferences.

    Patient Stories

    Patient Stories

    Real stories from patients affected by amyloidosis, showcasing their journeys.

    Impact Stats

    30

    Number of Grants Awarded

    Research Grants

    Annual grants for junior research scientists working on amyloidosis.

    3

    Number of Approved Drugs

    Established Treatment Options

    Support for the development of several drugs approved for treating ATTR amyloidosis.

    15

    Number of Webinars

    Patient Education Programs

    Hosted multiple webinars and informational sessions tailored to educate patients and caregivers.

    Past Events

    Emerging Treatments for AL Amyloidosis

    2024-10-15

    Webinar on Emerging Treatment Options for Amyloidosis

    Annual Patient Support Group Meeting

    2024-06-30

    Patient gathering to discuss experiences and resources.

    Amyloidosis Research Symposium

    2024-05-17

    Conference focused on new research breakthroughs.

    Upcoming Events

    Webinar: Understanding Neuropathy

    2024-11-20

    Join us for an informative session on managing neuropathy related to amyloidosis.

    Learn More

    Giving Tuesday

    2024-12-04

    Support our mission on this global day of giving.

    Learn More

    Webinar: Grace vs. Forgiveness

    2024-12-04

    A reflective session on coping strategies for patients and families.

    Learn More

    Our Programs

    Research Grants Program

    Provides funding to researchers focusing on amyloidosis to foster innovative treatments.

    Learn More

    Patient Resource Education

    Educational materials and webinars designed to empower patients and families.

    Learn More

    Awareness Campaigns

    Initiatives to raise public awareness about amyloidosis and its effects.

    Learn More

    Volunteer Opportunities

    Awareness Ambassador Program

    Help spread awareness about amyloidosis in your community.

    Learn More

    Event Support Volunteer

    Assist in the organization and execution of foundation events.

    Patient Outreach Volunteer

    Connect with patients to provide support and information.

    Testimonials

    "There is no greater reminder that we should cherish moments than nearly dying. My experience with amyloidosis taught me the importance of hope and resilience."
    Lou Catania

    Lou Catania

    "Being involved with the Amyloidosis Foundation has allowed me to make a difference in the lives of so many patients and their families."

    Patient Advocate

    Volunteer

    "The support from the Amyloidosis Foundation has been instrumental in advancing critical research that can lead to life-saving treatments."

    Researcher Partner

    Research Collaborator

    Impact Reports

    PDF Icon

    2024 Winter Newsletter

    PDF Icon

    2024 Spring Newsletter

    PDF Icon

    2024 Fall Newsletter

    MIP Score (Beta)

    The MIP Score is in beta! We'd love any feedback you may have.

    The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.

    Overall Score

    63

    54

    /100

    Program Expense Ratio

    84.37%

    16

    /20

    Program Revenue Growth

    0.00%

    2

    /20

    Leverage Ratio

    0.02026

    20

    /20

    Working Capital Ratio

    1.73

    14

    /20

    Fundraising Efficiency

    0

    2

    /20

    Latest Filing Data: Form 990

    Fiscal Year:2022

    Source:Source: Self-reported by organization

    Financial Details

    Revenue

    CategoryAmountPercentage
    Contributions, Gifts, and Grants606.8K85.41%
    Program Services00.00%
    Investment Income14.42K2.03%
    Sales of Non-Inventory Assets-5.583K-0.79%
    Other Notable Sources00.00%
    Total Revenue710.4K100.00%

    Related Nonprofits

    D S R F Down Syndrome Research Foundation

    D S R F Down Syndrome Research Foundation

    Med Research

    Down Syndrome Research
    Amyloidosis Foundation

    Amyloidosis Foundation

    Med Research

    Down Syndrome Research
    Briarcliff Business Partner Alliance

    Briarcliff Business Partner Alliance

    Med Research

    Down Syndrome Research
    Down Syndrome Innovations Inc.

    Down Syndrome Innovations Inc.

    Med Research

    Down Syndrome Research
    Kennedy Willis Center on Down Syndrome Inc.

    Kennedy Willis Center on Down Syndrome Inc.

    Med Research

    Down Syndrome Research

    Connect